![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euroapi-corp-ad-w30-desktop-header-1-2gif-57087.gif)
![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euro-api-mob-header-w30gif-19381.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.fiercepharma.com/pharma/argenxs-vyvgart-holds-its-own-against-astrazeneca-rivals-myasthenia-gravis-clash
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761195
https://www.globenewswire.com/news-release/2024/07/18/2915010/0/en/argenx-to-Report-Half-Year-2024-Financial-Results-and-Second-Quarter-Business-Update-on-July-25-2024.html
https://www.fiercebiotech.com/biotech/jj-unwraps-pivotal-data-65b-autoimmune-it-prepares-crash-argenx-and-ucbs-party
https://www.globenewswire.com/news-release/2024/06/25/2904146/0/en/argenx-Highlights-Breadth-of-Autoimmune-Pipeline-with-New-Multifocal-Motor-Neuropathy-Data-at-2024-Peripheral-Nerve-Society-Annual-Meeting.html
https://www.fiercepharma.com/pharma/argenx-snares-second-us-nod-vyvgart-hytrulo-fda-green-light-autoimmune-disease-cidp
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761304
https://www.globenewswire.com/news-release/2024/06/17/2899320/0/en/argenx-to-unveil-its-Vision-2030-Taking-Breakthrough-Science-to-50-000-Patients-during-its-Upcoming-R-D-Day-on-July-16-2024.html
https://endpts.com/argenx-drops-post-covid-syndrome-program-mirum-picks-a-dose-for-bile-duct-disease-drug/